Trial Profile
Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Erythema
- Focus Therapeutic Use
- Sponsors Allergan
- 30 Apr 2014 New trial record